abstract |
The present invention relates to a quinazoline-2,4-diketone salt compound containing piperazinone as a PARP1/2 inhibitor, a preparation method therefor, a pharmaceutical composition containing the compound, and a combined application of the compound serving as a medicine, especially as an antitumor drug or as a tumor drug sensitizer together with an antitumor drug. |